Gene and Cell Therapy – News and Features

See-through zebrafish have given researchers the opportunity to test a novel imaging method that provides insights into the inner workings of the blood stem cell environment.

In this interview with Bryan Kobel, CEO of TC Biopharm, we find out about gamma-delta T-cell therapy, including how it works, its applications and how TC Biopharm developed its pioneering gamma-delta treatment for acute myeloid leukemia.

The delivery of a protein that regulates the length of hair cell stereocilia and so is essential for hearing could aid in the development of gene therapies to repair hearing loss.

Researchers have now developed a special hydrogel that vastly improves the shelf life of vaccines, even without refrigeration.

Researchers report that a gene therapy approach measurably delayed disease onset in humanized mouse and rat models of an inherited form of ALS that runs in families.

Genetic mutations which cause a debilitating hereditary kidney disease affecting children and young adults have been fixed in patient-derived kidney cells using a potentially game-changing DNA repair-kit. The advance, developed by University of Bristol scientists, is published in Nucleic Acids Research.

Treating blinding retinal disorders by delivering healthy, stem cell-derived photoreceptor cells could be aided by a cocktail of immunosuppressive drugs that enables the cells to integrate with the retina.

Technology Networks spoke to Dr. Cenk Sumen, chief scientific officer of MaxCyte, about their pioneering cell engineering platform.

In this article, we discuss key challenges in vaccine development scale up, highlighting various strategies for overcoming them.

A study has mapped out how sensory interneurons form from stem cells, a key step in developing cell therapy to restore sensation in people with spinal cord injuries.